Cancer risk in patients with constitutional chromosome deletions: A nationwide British cohort study

British Journal of Cancer

Volumn 98, Issue 12, 2008, Pages 1929-1933

  Swerdlow, A J ^a   Schoemaker, M J ^a   Higgins, C D ^a   Wright, A F ^b   Jacobs, P A ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c SALISBURY DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Cohort; Constitutional chromosome deletions; Risk

Indexed keywords

ADOLESCENT; ADULT; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHROMOSOME 11P; CHROMOSOME 13Q; CHROMOSOME DELETION; COHORT ANALYSIS; EYE CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENITAL TRACT CANCER; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NEPHROBLASTOMA; PRIORITY JOURNAL; RETINOBLASTOMA; SKIN CANCER; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEOPLASMS;

EID: 44949155328     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604391     Document Type: Article

References (25)

1. Altman DG (1991) Practical Statistics for Medical Research. Boca Raton: Chapman & Hall/CRC
2. Bache I, Hasle H, Tommerup N, Olsen JH (2006) Population-based study of cancer among carriers of a constitutional structural chromosomal rearrangement. Genes Chromosomes Cancer 45: 231-246
3. Benitez J, Valcarcel E, Ramos C, Ayuso C, Cascos AS (1987) Frequency of constitutional chromosome alterations in patients with hematologic neoplasias. Cancer Genet Cytogenet 24: 345-354
4. Breslow NE, Day NE (1987) Statistical Methods in Cancer Research. Volume II - The Design and Analysis of Cohort Studies. IARC Scientific Publication No. 82. International Agency for Research on Cancer: Lyon
5. Cerretini R, Acevedo S, Chena C, Belli C, Larripa I, Slavutsky I (2002) Evaluation of constitutional chromosome aberrations in hematologic disorders. Cancer Genet Cytogenet 134: 133-137
6. DeBaun MR, Tucker MA (1998) Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 132: 398-400
7. Gasparini P, Sozzi G, Pierotti MA (2007) The role of chromosomal alterations in human cancer development. J Cell Biochem 102: 320-331
8. Grossfeld PD, Mattina T, Lai Z, Favier R, Jones KL, Cotter F, Jones C (2004) The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet 129A: 51-61
9. Hamerton JL, Canning N, Ray M, Smith S (1975) A cytogenetic survey of 14 069 newborn infants. I. Incidence of chromosome abnormalities. Clin Genet 8: 223-243
10. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CM, Stanbridge EJ, Evans GA (1994) Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91: 6953-6957
11. Jacobs PA, Browne C, Gregson N, Joyce C, White H (1992) Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding. J Med Genet 29: 103-108
12. Jones C, Slijepcevic P, Marsh S, Baker E, Langdon WY, Richards RI, Tunnacliffe A (1994) Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet 3: 2123-2130
13. Micci F, Teixeira MR, Scheistroen M, Abeler VM, Heim S (2003) Cytogenetic characterization of tumors of the vulva and vagina. Genes Chromosomes Cancer 38: 137-148
14. Mitelman F, Mertens F, Johansson B (1997) A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417-474
15. Muleris M, Salmon RJ, Girodet J, Zafrani B, Dutrillaux B (1987) Recurrent deletions of chromosomes 11q and 3p in anal canal carcinoma. Int J Cancer 39: 595-598
16. O'Sullivan MJ, Rader JS, Gerhard DS, Li Y, Trinkaus KM (2001) Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix. Hum Pathol 32: 475-478
17. Pinto AP, Lin MC, Mutter GL, Sun D, Villa LL, Crum CP (1999) Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas. Am J Pathol 154: 1009-1015
18. Pulido HA, Fakruddin MJ, Chatterjee A, Esplin ED, Beleno N, Martinez G, Posso H, Evans GA, Murty VV (2000) Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Cancer Res 60: 6677-6682
19. Skomedal H, Helland A, Kristensen GB, Holm R, Borresen-Dale AL (1999) Allelic imbalance at chromosome region 11q23 in cervical carcinomas. Eur J Cancer 35: 659-663
20. Smith DI, Zhu Y, McAvoy S, Kuhn R (2006) Common fragile sites, extremely large genes, neural development and cancer. Cancer Letters 232: 48-57
21. Swerdlow A, dos Santos Silva I, Doll R (2001) Cancer Incidence and Mortality in England and Wales: Trends and Risk Factors. Oxford: Oxford University Press
22. UCSC Genome Browser (2006) http://genome.ucsc.edu/cgi-bin/hgTracks
23. Welborn J (2004) Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies. Cancer Genet Cytogenet 149: 137-153
24. World Health Organization (1977) Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 9th revision, Vol 1. World Health Organization: Geneva
25. Yunis JJ (1983) The chromosomal basis of human neoplasia. Science 221: 227-236